Associate Professor of Clinical Medicine
; Director, GI Health Outcomes, Policy and Economics (HOPE) Research Program, UCSF
Chief, Clinical Gastroenterology, SFGH
GI Clinic, 3D
San Francisco General Hospital
San Francisco, CA 94110
Email:
jinadomi@medsfgh.ucsf.eduActive Projects:
- The impact of adherence on the cost-effectiveness of screening for colorectal cancer
- Socio-economic variation in patient-borne costs of cancer screening
- Evaluation of new techniques to decrease mortality from esophageal adenocarcinoma.
Techniques in Use:
- Cost-effectiveness analysis
- Cost-utility analysis
- Cost-benefit analysis
- Decision analysis
- Decision trees
- Markov models
- Sensitivity analysis
- Monte Carlo simulation
- Survey research
- Analytic and descriptive research, including clinical trials and case-control studies
Recent Publications:
Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. American Journal of Gastroenterology 2006;101:2200-2205.Inadomi JM, Sampliner R, Lagergren J, Lieverman D, Fendrick AM, Vakil N. Screening and surveillance for Barret esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med. 2004 Feb 4;138(3):176-86.
Dr. Inadomi's Biosketch